News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tokai Pharmaceuticals Appoints Daniel T. Dransfield, Ph.D. As Vice President, Head Of Translational Medicine


8/27/2014 8:59:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases, today announced the appointment of Daniel T. Dransfield, Ph.D. as vice president and head of translational medicine. Dr. Dransfield, formerly vice president of discovery research and translational medicine at ArQule, Inc., brings more than 20 years of drug development and research experience to Tokai.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES